If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

Life Science Washington, the state’s life sciences industry association, announced the expansion of its board of directors with the ad ...

CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zimmer Biomet Holdings (ZBH – Research Report), ...

Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...

Insmed's promising drug pipeline includes Brensocatib and Arikayce. See why INSM stock is a strong pick with multi-billion ...

A groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms of the condition hope for a ...

Carle Heath is stepping up its specialty care options this month for foot and ankle health at its Eureka hospital.

Palantir has burned bears and humbled Wall Street analysts who felt the stock was too rich at half the current price.